Mitiglinide Calcium

Mitiglinide Calcium is a medication used to manage and control blood glucose levels in patients with type 2 diabetes. The drug works by stimulating the release of insulin from the pancreas, which in turn helps to regulate blood sugar levels. Mitiglinide Calcium is often prescribed in combination with other diabetes medications or insulin therapy. The chemical name for Mitiglinide Calcium is (S)-2-benzyl-3-(cis-oxolan-2-yl) propanoic acid calcium salt hydrate. It belongs to a class of drugs called meglitinides, which are structurally similar to sulfonylureas. However, meglitinides have a shorter duration of action and are less likely to cause hypoglycemia than sulfonylureas. Mitiglinide Calcium is available in tablet form and is taken orally before meals. The recommended starting dose is 5mg, taken up to three times a day. The dosage may be adjusted based on the individual's response to treatment and blood glucose levels. The medication should not be taken if the patient is skipping meals or has a low blood sugar level. Like all medications, Mitiglinide Calcium has potential side effects. These include hypoglycemia, nausea, diarrhea, headache, and dizziness. Patients should inform their healthcare provider of any adverse effects experienced while taking the medication. In conclusion, Mitiglinide Calcium is a medication used to manage blood glucose levels in patients with type 2 diabetes. It works by stimulating the release of insulin from the pancreas. While effective, it should only be taken under the supervision of a healthcare provider and in conjunction with a healthy diet and exercise regimen.